STOCK TITAN
  1. Home
  2. Sec-filings
  3. G
  4. [Form 4] Genpact LTD Insider Trading Activity

Genpact insider reports sales; 50,569 shares remain owned

Filing Impact
(Very High)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Genpact (G) reported insider transactions by its SVP & Chief Legal Officer. On 11/11/2025, the officer sold 1,039 common shares at $44.02. On 11/12/2025 and 11/13/2025, the officer exercised employee stock options at $27.7 for 4,351 and 45,703 shares, respectively, and sold the corresponding shares at $45.74. Following these transactions, the officer directly beneficially owned 50,569 common shares. The reported option grant was scheduled to expire on 01/09/2029 and vested 50% on January 10, 2022 and 50% on January 10, 2024.

Positive

  • None.

Negative

  • None.
Insider White Heather
Role SVP & Chief Legal Officer
Sold 51,093 shs ($2.34M)
Type Security Shares Price Value
Exercise Employee Stock Option (Right to Buy) 45,703 $0.00 --
Exercise Common Shares 45,703 $27.70 $1.27M
Sale Common Shares 45,703 $45.74 $2.09M
Exercise Employee Stock Option (Right to Buy) 4,351 $0.00 --
Exercise Common Shares 4,351 $27.70 $121K
Sale Common Shares 4,351 $45.74 $199K
Sale Common Shares 1,039 $44.02 $46K
Holdings After Transaction: Employee Stock Option (Right to Buy) — 0 shares (Direct); Common Shares — 96,272 shares (Direct)
Footnotes (1)
  1. Includes 30 shares acquired under the Genpact Employee Stock Purchase Plan ("ESPP") since the reporting person's Form 4 filed on March 13, 2025. The reporting person currently holds a total of 560 shares under the ESPP. The option vested 50% on January 10, 2022 and 50% on January 10, 2024.
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
White Heather
(Last) (First) (Middle)
C/O GENPACT LLC
521 FIFTH AVENUE, 14TH FLOOR
(Street)
NEW YORK NY 10175
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Genpact LTD [ G ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
SVP & Chief Legal Officer
3. Date of Earliest Transaction (Month/Day/Year)
11/11/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Shares 11/11/2025 S 1,039 D $44.02 50,569(1) D
Common Shares 11/12/2025 M 4,351 A $27.7 54,920 D
Common Shares 11/12/2025 S 4,351 D $45.74 50,569 D
Common Shares 11/13/2025 M 45,703 A $27.7 96,272 D
Common Shares 11/13/2025 S 45,703 D $45.74 50,569 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Option (Right to Buy) $27.7 11/12/2025 M 4,351 (2) 01/09/2029 Common Shares 4,351 $0 45,703 D
Employee Stock Option (Right to Buy) $27.7 11/13/2025 M 45,703 (2) 01/09/2029 Common Shares 45,703 $0 0 D
Explanation of Responses:
1. Includes 30 shares acquired under the Genpact Employee Stock Purchase Plan ("ESPP") since the reporting person's Form 4 filed on March 13, 2025. The reporting person currently holds a total of 560 shares under the ESPP.
2. The option vested 50% on January 10, 2022 and 50% on January 10, 2024.
Remarks:
/s/ Thomas D. Scholtes, as Attorney-in-fact for Heather White 11/13/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What insider transactions did Genpact (G) report?

The SVP & Chief Legal Officer sold 1,039 shares at $44.02 on 11/11/2025, and on 11/12–11/13/2025 exercised options at $27.7 and sold the resulting shares at $45.74.

How many options were exercised by the Genpact officer?

Two exercises: 4,351 shares on 11/12/2025 and 45,703 shares on 11/13/2025, both at an exercise price of $27.7.

At what prices were shares sold in these transactions for G?

Sales occurred at $44.02 on 11/11/2025 and at $45.74 on 11/12/2025 and 11/13/2025.

How many Genpact shares does the reporting person own after these trades?

The filing shows 50,569 common shares directly beneficially owned following the reported transactions.

What are the key terms of the exercised options?

The options had an exercise price of $27.7, vested 50% on January 10, 2022 and 50% on January 10, 2024, and were set to expire on 01/09/2029.

What is the reporting person’s role at Genpact (G)?

The reporting person is an officer, serving as SVP & Chief Legal Officer.